ARTICLES

Designing adherence programs: Local is better than global

Angelo DePalma, Aug 23, 2010 Kenneth Youngstein, CEO of Biocom, on the regulatory, strategic, and tactical challenges of cross-border compliance programs.

Compliance and the corporate brand

Di Stafford, Aug 23, 2010 Di Stafford explores role pharma corporate brands can play in medicine adherence.

The role of new technologies in enhancing compliance

Peter Mansell, Jul 27, 2010 Peter Mansell reports on how compliance and personal monitoring technologies can help pharma firms better tailor their offerings to different patient groups

Q&A: The role of the caregiver in brand loyalty and compliance

Andrew Tolve, Jul 27, 2010 Rebecca Joslin, brand associate director for Novartis’ Exelon Patch, on how reaching out to caregivers creates brand loyalty and improves adherence

Compliance and the older patient: How the Web can help

Di Stafford, Jul 27, 2010 Di Stafford explains how customized digital communication can assist pharma in successfully engaging with older patients

Adherence and the empowered patient

Peter Mansell, Jun 28, 2010 Peter Mansell explains how patient access to new technologies and new data could impact everything from compliance to cost-benefit analyses.

The pharmacist's role in patient adherence

Les Rose, Jun 28, 2010 Ema Paulino, a member of the board of the Italian National Association of Pharmacies, talks to eyeforpharma about the role of the pharmacist and technology in improving patient compliance.

Compliance and social marketing: a new opportunity for collaboration

Di Stafford, Jun 28, 2010 Di Stafford explains why social marketing, rather than social media, may offer the best prospects for improving adherence.

BLOGS

Learning to take our medicine

Malcolm Allison, Aug 23, 2010 Why a little dose of fear is good for compliance.

Mal’s Musings: It’s time for pharma to get serious about CSR

'Mal Barnard', Jul 26, 2010 Why future success should be measured by gains in corporate social responsibility (CSR) as well as in share price  

Southwest Airlines and Pharma Content Creation: What’s the Connection?

Sam Agris, Jul 08, 2010 I spend a fair amount of time on airplanes for business and some for pleasure and always try to take the nonstop flight to my destination.

What consumers want in DTC ads

Richard Meyer, Jul 06, 2010 A group of consumer, senior, patient safety organizations and small insurers, including Community Catalyst and various state public interest research groups, filed their own comments with the FDA o

Mal’s Musings: Segmentation, Segmentation, Segmentation

'Mal Barnard', Jun 21, 2010 Customers differ! They differ in characteristics, needs, and the way they respond to our value propositions.

Digital spend: the chicken or the egg?

fschenck, May 28, 2010 Quantifying industry e-spend “How much of our sales and marketing spend should go to digital?” That’s a question we often get. 5%? 10%? More? Less?

The three account selling disciplines

Torsten v. Bernewitz, May 26, 2010 Ask five pharma companies what KAM is and you may get three to five different answers.Ask a consultant and the answer is probably “it depends”. And they are probably all right. 

Mal’s Musings: Is Value-based Selling (VBS) Just Plain BS?

'Mal Barnard', Apr 27, 2010 For decades, most business enthusiasts have propagated the relationship between value and customers. Yet we find ourselves constantly being challenged about the value we deliver.

User login

Patient Adherence & Engagement USA

October 19-20, 2010 - Philadelphia - Click here

19/10/2010 - 16:50
20/10/2010 - 16:50
Etc/GMT

Patient Adherence & Engagement USA 2010